Accumulation of genetic and epigenetic changes alters regulation of a web of interconnected genes including microRNAs (miRNAs), which confer hallmark capabilities and characteristic cancer features. In this study, the miRNA and messenger RNA expression profiles of 126 non-small cell lung cancer specimens were analyzed, with special attention given to the diversity of lung adenocarcinomas. Of those, 76 adenocarcinomas were classified into two major subtypes, developing lung-like and adult lung-like, based on their distinctive miRNA expression profiles resembling those of either developing or adult lungs, respectively. A systems biology-based approach using a Bayesian network and non-parametric regression was employed to estimate the gene regulatory circuitry functioning in patient tumors in order to identify subnetworks enriched for genes with differential expression between the two major subtypes. miR-30d and miR-195, identified as hub genes in such subnetworks, had lower levels of expression in the developing lung-like subtype, whereas introduction of miR-30d or miR-195 into the lung cancer cell lines evoked shifts of messenger RNA expression profiles toward the adult lung-like subtype. Conversely, the influence of miR-30d and miR-195 was significantly different between the developing lung-like and adult lung-like subtypes in our analysis of the patient data set. In addition, RRM2, a child gene of the miR-30d-centered subnetwork, was found to be a direct target of miR-30d. Together, our findings reveal the existence of two miRNA expression profile-defined lung adenocarcinoma subtypes with distinctive clinicopathologic features and also suggest the usefulness of a systems biology-based approach to gain insight into the altered regulatory circuitry involved in cancer development.
Introduction
Lung cancer has long been the leading cause of cancer-related deaths worldwide; thus, a better understanding of the molecular pathogenesis of this fatal disease is keenly awaited to reduce the intolerable death toll. Adenocarcinomas arising from peripheral lung tissues are the most frequent histological type and exhibit the highest degree of diversity among various types of lung cancers (1) . The TTF-1 transcription factor, a master regulator of peripheral lung development, is expressed in a series of peripheral lung epithelial cells belonging to a distinct cellular lineage, i.e. 'terminal respiratory unit (TRU)', and has also been shown to play a role as a lineage-survival oncogene of lung adenocarcinoma (2) (3) (4) . Our previous studies demonstrated the existence of two major types of lung adenocarcinomas, i.e. TRU and non-TRU types (3, 5) . A TRU-type adenocarcinoma characteristically retains features of TRU cells to a certain extent and exhibits uniform and abundant TTF-1 expression as well as distinct messenger RNA (mRNA) expression profiles in association with a high prevalence of epidermal growth factor receptor mutations, female gender and nonsmoking status (3, 5, 6) .
Lung cancers carry various genetic and epigenetic alterations in cancer-related, protein-coding genes (7, 8) , while accumulated evidence also indicates that microRNAs (miRNAs) are involved in lung cancer development (9) . We reported previously that let-7 plays a role as a tumor suppressor miRNA in lung cancers and showed frequent downregulation in association with poor postoperative prognosis (10) , whereas the oncogenic miRNA (oncomiR) miR-17-92 is frequently overexpressed with occasional gene amplification, rendering lung cancer cells addicted to continued expression for cell survival (11) (12) (13) (14) . It is interesting to note that close relationships of both let-7 and miR-17-92 with development and proliferation have been demonstrated, suggesting a possible mechanistic link between altered miRNA expression and cancer development (15, 16) .
Accumulation of multiple genetic and epigenetic alterations in the cancer genome affects regulation of a web of interconnected genes including miRNAs. The resultant global changes in expression of both protein-coding genes and miRNAs establish a molecular basis for acquisition of hallmark capabilities and characteristic features of cancer cells (17) . Although information regarding intergene regulatory relationships and their cascades is steadily accumulating, the entire picture of the gene regulatory circuitry remains elusive, especially regarding its operation in tumor tissues of cancer patients. Along this line, there is expectation that a cancer systems biology approach will help to reveal a path to resolve this challenge with the aid of ever-increasing computing power (18) .
In this study, we analyzed the global expression profiles of miRNAs together with those of mRNAs in non-small cell lung cancer (NSCLC) tissues, with special attention given to the diversity of lung adenocarcinomas. We also employed a systems biology-based approach in order to identify the gene regulatory circuitry, which is distinctively involved in two major lung adenocarcinoma subtypes that are definable by their miRNA expression profile.
Materials and methods

Tumor samples and cell line
A series of 126 NSCLC cases, comprising 76 adenocarcinomas, 29 squamous cell carcinomas, 15 large cell carcinomas, 4 adenosquamous carcinomas and 2 large cell neuroendocrine carcinomas, which successfully underwent potential curative resection at Aichi Cancer Center, Nagoya, Japan, were investigated. All tumors were histologically categorized according to the IASLC/ ATS/ERS classification (1) . Approval of the institutional review boards of Nagoya University Graduate School of Medicine and Aichi Cancer Center and written informed consent from the patients were obtained. All tumor specimens were embedded in OCT compound and stored at −80°C. Seventysix of the adenocarcinoma cases were included in an analysis of the association between miRNA expression profile-defined subtypes and postoperative prognosis. The median follow-up period of the patients was 79 months (range, 1-111 months) when all eligible cases were included and 91 months (63-111 months) after excluding deceased cases. SK-LC-7 and SK-Lu-1, lung adenocarcinoma cell lines, were gifts from late Dr Lloyd J. Old (Memorial Sloan Kettering Cancer Institute) and maintained in RPMI-1640 with 5% fetal bovine serum (19, 20) . Detailed information regarding their verification is provided in the Supplementary Materials and methods, available at Carcinogenesis Online.
Abbreviations: miRNA, microRNA; mRNA, messenger RNA; NSCLC, nonsmall cell lung cancer; TRU, terminal respiratory unit.
miRNA profile-defined lung adenocarcinoma subtypes
Microarray analysis of miRNA and mRNA expression profiles Frozen tissues from the tumor specimens were subjected to gross microdissection under the guidance of a pathologist (Y.Y.) to ensure at least 50% tumor cell content using every 10th section stained with Giemsa. Total RNA was extracted using an miRNeasy Mini kit (Qiagen), followed by treatment with DNase I. Microarray analysis was conducted to examine miRNA expression profiles using a Human miRNA Microarray (precommercial version, Agilent) with 470 miRNA probes, according to the manufacturer's instructions. Microarray analysis was also conducted to examine the effects of miR30d and miR-195 on mRNA expression, using Whole Human Genome 4x44K Microarrays (G4112F, Agilent) and a large batch of common reference RNA of a mixture of 20 lung cancer cell lines, as described previously (21) . We also utilized our previous data sets of mRNA expression profiles (21) and EGFR, K-ras and p53 mutations (5) of the same lung adenocarcinoma sample set, except for a single case. In addition, microarray analysis was newly conducted to acquire mRNA expression profile data for the non-adenocarcinoma samples used in this study, which included 49 NSCLC tumor samples with a histology other than adenocarcinoma (a single squamous cell carcinoma specimen was not available for the additional analysis) and four mixtures of normal lung tissues. All microarray data obtained in this study are available at the Gene Expression Omnibus under the following accession number (GSE51855).
Bioinformatics and systems biology-based analyses
Microarray analysis data of miRNA expression were first log2-transformed and normalized to the 75th percentile, followed by filtering to select miRNAs with expression in at least 10% of the samples. Consequently, 303 miRNAs were selected for subsequent hierarchical clustering analysis of the NSCLC samples and 299 for the adenocarcinoma samples. The CLUSTER program was used to perform average linkage hierarchical clustering, using median centering for normalization and uncentered correlation coefficient, and the results were displayed with the aid of TREEVIEW (http://rana.lbl.gov/EisenSoftware. htm) (22) . The Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/home.jsp) was used for pathway analysis along with the Kyoto Encyclopedia of Genes and Genomes with false discovery rate (FDR) <25% set as the significance level. Fisher's exact test was used for comparisons of proportions according to the miRNA expression profiledefined subtypes in hierarchical clustering analysis. The Kaplan-Meier method was used to estimate survival as a function of time and survival differences were analyzed with a log-rank test with P < 0.05 set as the significance level. Statistical analyses were performed using Stata software (version 7, StataCorp).
For analysis of the relationship of miRNA expression profile-based subtypes with lung development, we selected 18 and 38 miRNAs corresponding to clusters 5 and 1, respectively, in a previous report by Dong et al. (23) (GSE21052), which were most specifically expressed in developing and adult lung-predominant types, respectively. Similarly, we used a data set reported by Dong et al. (23) (GSE20954 with use of an Affymetrix GeneChip Mouse Genome 430 2.0 Array) to select mRNAs predominantly expressed in either developing or adult lungs. Among 4414 genes that passed filtering for expression and also corresponded to probes on a Whole Human Genome 4x44K Microarray chip (G4112F, Agilent), 2078 developing lung-and 1778 adult lung-predominant mRNAs were consequently identified and subjected to one-way hierarchical clustering analysis (Supplementary Figure 1 , available at Carcinogenesis Online). The average z-scores of each set of genes in clusters 1 and 2 were calculated and then subjected to box plot analysis. A Wilcoxon rank sum test was used to evaluate statistical significance. Statistical analyses were performed with R software version 3.0.1 (http://www.r-project.org) and the two-sided significance level was set at P < 0.05.
The gene regulatory network was estimated using SiGN-BN, a Bayesian network and non-parametric regression-based software package, using a supercomputer at the Human Genome Center, Institute of Medical Science, University of Tokyo (http://sign.hgc.jp/signbn/) (24) . SiGN-BN estimates regulatory dependencies between genes as gene networks from gene expression data. We made slight modifications to SiGN-BN in order to reconcile our assumption that miRNAs do not have direct regulatory consequences with other miRNAs (Supplementary Materials and methods, available at Carcinogenesis Online). Among 464 mRNAs belonging to an Ingenuity Pathway Analysis category of lung tumor (cancer > lung tumor > lung tumor), and 141 mRNAs belonging to an Ingenuity Pathway Analysis category of respiratory system development and function (development > respiratory system development and function), except for those in its subcategories of development of the nose and diaphragm and related cell lines, we selected those exhibiting more than a 2-fold difference in samples between the 10 and 90% tiles in 124 NSCLCs, for which both miRNA and mRNA expression profiles were available. As a result, 400 mRNAs and 32 miRNAs were selected for network estimation with 0.05 used as the bootstrap threshold. In this study, a gene estimated to be in regulatory relationships with multiple genes was defined as a hub gene and those estimated to have regulatory relationships with a hub gene were called child genes.
Experimental evaluations by introduction of miR-30d or miR-195
Pre-miR-30d, Pre-miR-195 and Pre-miR-NC#2 were purchased from Ambion. Each Pre-miR molecule was introduced into 1 × 10 5 of SK-LC-7 and SK-Lu-1 cells with low miR-30d and miR-195 expression using 1 μl/ml of Lipofectamine RNAiMAX (Invitrogen) according to the instructions of the manufacturer. Cells were harvested 72 h after transfection and subjected to western blotting, flow cytometric and colorimetric analyses, essentially as described previously (25, 26) . Changes in global mRNA expression were also analyzed by microarray analysis as described above. In addition, influences of miR-30d or miR-195 in patients with an adenocarcinoma were estimated. To this end, we first selected genes with a differential expression of >0.5 either up or down (log2 ratio) in response to miRNA introduction in SK-LC-7, from those included in the network estimation. Consequently, 77 and 118 mRNAs were identified as those affected by miR-30d and miR-195 introduction, respectively. We then defined the influence score for each patient based on the following equation in order to evaluate the concordance of expression of miR-30d or miR-195 with changes in these 77 and 118 mRNAs: .
Wilcoxon rank sum and Kruskal-Wallis tests were used for comparisons of influence scores between the two clusters and among five subclusters, respectively. Statistical analyses were performed with R software version 3.0.1 and the two-sided significance level was set at P < 0.05.
A 2033 bp RRM2 3′ untranslated region containing a target site for miR-30d was amplified by PCR using primers with the SfiI site and cloned downstream of the luciferase coding sequence in the modified pGL3 vector. The following primers were used to amplify the 3′ untranslated region: forward, 5′-AA AGGCCAG TAGGGCCATGAACTGAAGATGTGCCCTTACTTGG-3′; and reverse, 5′-GGC CCTACTGGC CGAAAC TGACATAAGAACAG-3′. To generate a mutation in the predicted target site, seven nucleotides corresponding to the seed sequence were deleted using a QuikChange site-directed mutagenesis kit (Stratagene). A luciferase assay was performed using the resultant vectors, as described previously (26) .
Results
Existence of two major types of lung adenocarcinomas according to miRNA expression profiles
Microarray analysis was performed to analyze the miRNA expression profiles of tumor samples from 126 surgically treated NSCLC patients as well as five sets of RNA mixtures, each of which contained five independent normal lung RNAs (25 samples in total). We first performed unsupervised hierarchical clustering based on the expression of 303 miRNAs with expression detected in at least 10% of the NSCLC samples, in order to gain insight into the diversity of NSCLC in relation to miRNA expression profiles. In contrast to our previous mRNA expression profiling analysis recapitulating the widely used histologic classification of NSCLCs (5), adenocarcinomas were not grouped into a single well-defined cluster ( Figure 1A) . Instead, they were found not only in a cluster primarily consisting of adenocarcinomas along with normal lung tissues but also in the other major cluster containing an admixture of both adenocarcinomas and other histologic types such as squamous cell carcinomas. We then focused our attention specifically to adenocarcinoma diversity. Hierarchical clustering analysis of 76 lung adenocarcinomas was conducted based on the expression of 299 miRNAs with expression in at least 10% of the adenocarcinoma samples ( Figure 1B ). Cluster 1 with two subclusters was composed of tumors belonging to the admixture cluster in the analysis of NSCLCs. We found that cluster 1 tumors were significantly associated with a less differentiated state, as well as more prominent invasion and necrosis (Table I ). In contrast, the mRNA expression profile-defined TRU-type classification was significantly more commonly seen in cluster 2 with three subclusters, one of which had expression profiles considerably similar to that of normal lung tissue. Mutations in the EGFR, p53 and K-ras genes were not differentially present. Kaplan-Meier survival curves demonstrated significant differences in relapse-free survival among the clusters, whereas no relapse was observed in cluster 2a with expression profiles very similar to that of normal lung tissue. These findings indicated that lung adenocarcinomas can be classified into two major subtypes according to their miRNA expression profiles, showing a distinctive association with clinicopathologic features including postoperative prognosis.
Relationship of two major adenocarcinoma clusters with developmental state of the lung
It is well accepted that miRNAs play important roles in developmental processes (9); thus, we investigated whether miRNA expression profile-defined subtypes of lung adenocarcinomas may reflect the expression of various miRNAs, which are distinct between developing and adult lungs. To this end, we performed one-way hierarchical clustering analysis according to the expression of 18 miRNAs shown to be predominantly expressed in fetal lung tissues and of 38 predominantly expressed in adult lung tissues (23) . A clear difference in lung development-related miRNA expression was readily observed between clusters 1 and 2, as tumor samples belonging to cluster 1 exhibited distinctively high expression of developing lung-predominant miRNAs, whereas those of cluster 2 expressed adult lung-predominant miRNAs at a significantly higher level than seen in cluster 1 (Figure 2A) . We also performed one-way hierarchical clustering analysis according to the mRNA expression profiles of a set of protein-coding genes, which we selected based on their predominance in developing and adult mouse lungs (Supplementary Figure 1 , available at Carcinogenesis Online). As with miRNA expression, developing and adult lung-predominant mRNAs were preferentially expressed at a high level in clusters 1 and 2, respectively (Supplementary Figure 2 , available at Carcinogenesis Online). These findings supported the notion that the distinctive expression profiles of the two miRNA expression profile-defined subtypes may reflect the regulatory state related to lung development, although the association of cluster 1 with aggressive clinicopathologic features appeared to be consistent with an intrinsic highly proliferative state.
Estimation of gene regulatory circuitry in tumors from lung adenocarcinoma patients
We next attempted to determine the gene regulatory circuitry involving both miRNAs and mRNAs in the two miRNA expression profiledefined subtypes of lung adenocarcinomas. For this, we estimated the genetic network using SiGN-BN software (24) (Figure 3A) . We then extracted a subset of the estimated network, which was accordingly composed of subnetworks that were significantly enriched for genes with differential expression between clusters 1 and 2 (P < 0.001, with Bonferroni adjustment). As a result, 19 subnetworks along with their hub genes were identified and found to be enriched for genes of Fig. 2 . Hierarchical clustering analysis of lung adenocarcinomas based on (A) lung development-related miRNA expression profiles and (B) comparisons of average z-scores for developing lung-and adult lung-predominant miRNAs between clusters 1 and 2. P values calculated using Wilcoxon rank sum test. the Kyoto Encyclopedia of Genes and Genomes pathways including cell cycle, nucleic acid metabolism and DNA repair ( Figure 3B and Supplementary Table 1 , available at Carcinogenesis Online). Child genes, which represent those under either direct or indirect regulatory relationships with hub genes, were often shared among the 19 significantly enriched subnetworks (Supplementary Table 2 , available at Carcinogenesis Online), suggesting their close regulatory relationships. We also identified two miRNAs, miR-30d and miR-195, as hub genes of the significantly enriched subnetworks, as they showed lower levels of expression in cluster 1 than in cluster 2. In order to experimentally evaluate the effects of miR-30d and miR-195 on the estimated gene regulatory circuitry, miRNA mimics of miR-30d or miR-195 were transfected into SK-LC-7 cells expressing these miRNAs at a low level. Introduction of these hub miRNAs altered the expression of their child genes in a manner that considerably mimicked their expression in cluster 2 ( Figure 4A and 4B) . Similar effects were observed in miR-30d-transfected SK-Lu-1 cells (Supplementary Figure 3A , available at Carcinogenesis Online). It was notable that miR-30d markedly decreased ribonucleotide reductase M2 (RRM2), one of the child genes of the miR-30d-centered subnetwork and a predicted target for miR-30d, as shown by the TargetScan program. Also, western blotting analysis clearly showed downregulation of RRM2 in response to treatment with miR-30d mimics in SK-LC-7 and SK-Lu-1 cells ( Figure 4C and Supplementary Figure 3B , available at Carcinogenesis Online), whereas introduction of miR-30d significantly altered cell cycle distribution, resulting in an increase in the G 1 phase and a decrease in S ( Figure 4D ), as well as inhibition of cell proliferation ( Figure 4E and Supplementary Figure 3C , available at Carcinogenesis Online). Direct repression of RRM2 by miR-30d via its binding to the predicted target site at the 3′ untranslated region was confirmed by luciferase assay findings ( Figure 4F ). We then examined whether introduction of miR-30d or miR-195 evoked a shift of the expression profile toward a cluster 2-like one ( Figure 5A ). Although both miRNAs were expressed at higher levels in cluster 2 than in cluster 1, introduction of either of the two miRNAs broadly affected the expression profiles, leading to decreased expression of genes that were expressed at higher levels in cluster 1 than in cluster 2 and vice versa ( Figure 5A ). Conversely, genes affected by introduction of miR-30d or miR-195 in vitro were found to be under differential influences of these miRNAs between tumors in clusters 1 and 2, showing that they had a significantly greater influence in cluster 2, which had higher expression of the two miRNAs than cluster 1 ( Figure 5B and Supplementary Figure 4 , available at Carcinogenesis Online).
Discussion
The present findings clearly demonstrate the existence of two major subtypes in lung adenocarcinomas based on their distinctive miRNA expression profiles. A group of tumors with high expression of developing lung-predominant miRNAs (cluster 1) including components of the miR-17-92 cluster (15, 16) were associated with aggressive growth, as manifested by prominent invasion and necrosis reflecting excessive proliferation, as well as poor prognosis after surgery. In marked contrast, the other major cluster (cluster 2) exhibited miRNA expression profiles similar to those of adult normal lung tissues and considerably retained normal lung characteristics such as the presence of TRU type and early phase of adenocarcinoma. Along this line, though the number of patients was small, those in subcluster 2a with expression profiles most reminiscent of adult normal lung tissues had no recurrence after surgery. Our previous finding of frequent downregulation of let-7 in association with poor prognosis in lung cancer (10) may well correspond to the existence of tumors belonging to cluster 1, in which not only let-7 but also other adult lung-predominant miRNAs with a gradual increase over the course of lung development were generally downregulated together, suggesting possible involvement of a coregulatory mechanism(s).
Our systems biology approach employing a Bayesian network and non-parametric regression allowed us to estimate the gene regulatory circuitry engaged in tumors of lung adenocarcinoma patients. A substantial proportion of the subnetworks identified as enriched for genes with differential expression between clusters 1 and 2 also exhibited enrichment of genes with proliferation-related functions, such as cell cycle and biomass production. This appears to be consistent with the finding that tumors in cluster 1 with poor prognosis exhibited both miRNA and mRNA expression profiles reminiscent of developing lungs, in which active cell proliferation takes place. In marked contrast, cluster 2 tumors with favorable prognosis showed resemblance to the expression profiles of adult lung tissues, which are populated with mostly quiescent epithelial cells (27) . Thus, the present findings support the notion that lung adenocarcinomas can be divided into two major subtypes according to miRNA expression profiles, which seem to reflect either an actively proliferating developing lung-like biologic state or a well-committed adult lung-like state. Thus, it is possible that developmental machinery is involved in the acquisition of distinctive expression profiles and biologic features, warranting a future investigation to gain further insight into the driving force of that process.
The identified hub genes included two miRNAs, miR-30d and miR-195, and experimental evaluations clearly showed that introduction of either one altered the mRNA expression profiles to resemble those of cluster 2, confirming their pivotal roles in the regulatory circuitry. Consistent with our experimental findings, we also observed that the regulatory influences of miR-30d and miR-195 were more obvious in tumors belonging to cluster 2 than cluster 1, whereas these miRNAs were also expressed at higher levels in the former group. Thus, these miRNAs indeed appear to be engaged in tumors in gene regulation in vivo, which conceivably confers characteristic features of the miRNA expression profile-defined subtypes of lung adenocarcinomas. Our results also revealed that miR-30d directly targets RRM2, which was estimated to be a child gene in the miR-30d-centered subnetwork in (E) colorimetric analyses were performed using SK-LC-7 cells introduced with either miR-30d mimics or negative control (NC). (F) Luciferase assay findings obtained using reporter vector carrying either 3′ untranslated region of RRM2 harboring potential miR-30d binding site or that with a 7-bp deletion corresponding to the seed sequence of miR-30d. *P < 0.05; **P < 0.005.
